Furthermore, the regulatory network of MHC-II+ cancer cells revealed interactions between PVR and coinhibitory receptors including TIGIT and CD96, which induce CD8+ T-cell exhaustion and Treg activation, and subsequently facilitate immune evasion 47. Here, PVR is linked to cancer.